{"id":"W2802172791","doi":"10.1200/jco.2017.77.2293","title":"Patient-Reported Symptoms and Impact of Treatment With Osimertinib Versus Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The AURA3 Trial","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pfizer (Canada)","funders":"AstraZeneca","keywords":"Medicine; Lung cancer; Quality of life (healthcare); Internal medicine; Odds ratio; Hazard ratio; Cancer; Clinical trial; Performance status; Confidence interval; Chemotherapy; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004028024,0.0009233566,0.001574559,0.0001992168,0.0003359328,0.001044882,0.0005642147,0.001149282,0.002104401],"category_scores_gemma":[0.002540564,0.0001894547,0.002641599,0.0004933665,0.0006429863,0.0007402411,0.0004390751,0.002243711,0.0002978775],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005381203,"about_ca_system_score_gemma":0.0007006377,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005803502,"about_ca_topic_score_gemma":0.001330317,"domain_scores_codex":[0.9981219,0.001317691,0.000117888,0.0001708651,0.0001281289,0.000143422],"domain_scores_gemma":[0.9979047,0.0005779646,0.0008144818,0.000165591,0.00007507856,0.0004622222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9100791,0.003686497,0.02883198,0.001411077,0.005891482,0.0001255692,0.0001031534,0.001682905,0.002090849,0.0003783922,0.004146906,0.0415721],"study_design_scores_gemma":[0.6842098,0.136426,0.1538603,0.0003077263,0.01017478,0.0005786566,0.0001451553,0.004079041,0.001433717,0.002123078,0.006551872,0.0001098364],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9830769,0.01083444,0.0002402297,0.001099305,0.000282947,0.0004698919,0.001762435,0.00003796317,0.002195932],"genre_scores_gemma":[0.9950438,0.001544592,0.000233347,0.0006628043,0.0003896526,0.0006229559,0.000981694,0.000007770554,0.0005134901],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004028024,"threshold_uncertainty_score":0.02130246,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05406334905879762,"score_gpt":0.4881889375538155,"score_spread":0.4341255884950179,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}